(Q26853671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4 references

30 May 2020

20 July 2020

20 October 2022

25 October 2022

Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

RNA virus infectious disease

29 February 2020

main subject

1 reference

1 July 2020

1 reference

20 July 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Magdalena Harris

series ordinal

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

7 May 2013

10 references

19 March 2019

23 March 2019

21 March 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

30 May 2020

1 July 2020

20 July 2020

20 October 2022

25 October 2022

Harm Reduction Journal

10 references

19 March 2019

23 March 2019

21 March 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

30 May 2020

1 July 2020

20 July 2020

20 October 2022

25 October 2022

10

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

29 February 2020

copyright license

8 references

19 March 2019

23 March 2019

21 March 2019

30 May 2020

1 July 2020

20 July 2020

20 October 2022

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

25 October 2022

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Outcomes of treatment for hepatitis C virus infection by primary care providers

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Barriers to hepatitis C treatment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C virus infection in san francisco’s HIV-infected urban poor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Diagnosis, management, and treatment of hepatitis C: an update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Taming systems to create enabling environments for HCV treatment: negotiating trust in the drug and alcohol setting

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Enhancing Drug Treatment Program Staff's Self-Efficacy to Support Patients' HCV Needs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Predictors of deferral of treatment for hepatitis C infection in Australian clinics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Does geographic access to primary healthcare influence the detection of hepatitis C?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C management: the challenge of dropout associated with male sex and injection drug use.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

HIV and risk environment for injecting drug users: the past, present, and future.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Successful integration of hepatitis C evaluation and treatment services with methadone maintenance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C treatment experiences and decision making among patients living with HIV infection.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Social and structural determinants of HAART access and adherence among injection drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Viral hepatitis in incarcerated adults: a medical and public health concern

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C: a medical and social diagnosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Prisons and HCV: a review and a report on an experience in New South Wales Australia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Obstacles to successful HCV treatment in substance addicted patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Limited uptake of hepatitis C treatment among injection drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Socioeconomic context, distance to primary care and detection of hepatitis C: a French population-based study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Homelessness, drug use and hepatitis C: a complex problem explored within the context of social exclusion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Integrating HCV services for drug users: a model to improve engagement and outcomes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

The depiction of stigmatization in research about hepatitis C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Offers of hepatitis C care do not lead to treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Adherence in antiretroviral therapy: a review of qualitative studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

The patient experience of treatment for hepatitis C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

The Everyday Violence of Hepatitis C Among Young Women Who Inject Drugs in San Francisco

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

New psychiatric and psychological aspects of diagnosis and treatment of hepatitis C and relevance for opiate dependence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Barriers to health and social services for street-based sex workers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Factors to improve the management of hepatitis C in drug users: an observational study in an addiction centre

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Correlates of hepatitis C virus infection in homeless men: a latent variable approach

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Treating hepatitis C virus infection in active substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Treatment of hepatitis C infection for current or former substance abusers in a community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

"Look, I'm fit, I'm positive and I'll be all right, thank you very much": coping with hepatitis C treatment and unrealistic optimism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Hepatitis C knowledge among primary care residents: is our teaching adequate for the times?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Educational and health service needs of Australian general practitioners in managing hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Alcohol use and treatment of hepatitis C virus: results of a national multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Follow-up studies of treatment for hepatitis C virus infection among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Intricacies and inter-relationships between HIV disclosure and HAART: a qualitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Viral hepatitis and other infectious diseases in a homeless population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Treating hepatitis C in methadone maintenance patients: an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Risk environments and drug harms: A social science for harm reduction approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1477-7517-10-7

Hepatitis C treatment completion in individuals with psychiatric comorbidity and depression.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Theorising stigma and the experiences of injecting drug users in Australia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Reinfection with hepatitis C virus following sustained virological response in injection drug users

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C treatment in pharmacotherapy services: increasing treatment uptake needs a critical view.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Experience of hepatitis C among current or former heroin users attending general practice.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Knowledge of and interest in hepatitis C treatment at a methadone clinic

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Australian women's experiences of living with hepatitis C virus: results from a cross-sectional survey

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3686576

Disclosing hepatitis C infection within everyday contexts: implications for accessing support and healthcare

28 November 2018

1 reference

12 December 2020

The experience of interferon-based treatments for hepatitis C infection

1 reference

12 December 2020

Now, later or never? Challenges associated with hepatitis C treatment

1 reference

12 December 2020

Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?

1 reference

12 December 2020

Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C

1 reference

12 December 2020

A diagnosis of hepatitis C - insights from a study on patients' experiences

1 reference

12 December 2020

Patients' experiences related to anti-viral treatment for hepatitis C

1 reference

12 December 2020

Improving access to HCV treatment: external jugular venepuncture can overcome problems with difficult venous access

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7517-10-7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 February 2020

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1477-7517-10-7

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

23651646

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651646%20AND%20SRC:MED&resulttype=core&format=json